Regenn® Therapy System Safety Study

NCT06259409 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Progenerative Medical, Inc